Literature DB >> 1283864

Histological pancreatitis in end-stage renal disease.

T Araki1, M Ueda, K Ogawa, T Tsuji.   

Abstract

To clarify a possible cause of hyperamylasemia in end-stage renal disease (ESRD), histological studies were performed on the pancreatic glands of twenty-seven autopsied patients with ESRD who had received long-term hemodialysis. The findings were compared with those in a similar number of age-matched control subjects. Histological evidence of pancreatitis was found in 51.9% of the ESRD patients as compared with 14.8% in the controls (p < 0.005). The pancreatitis was chronic in nature in 85.7% of the ESRD patients showing changes of pancreatitis. Secretin administration to an additional group of twelve patients with ESRD induced an elevation in the activities of both total and P-type serum amylase in only one patient. These findings suggest that although histological pancreatic alterations are common in patients with ESRD, they are probably not responsible for the P-type hyperamylasemia frequently found in such patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283864     DOI: 10.1007/bf02924366

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  8 in total

1.  The pancreas in uremia; a histopathologic study.

Authors:  A H BAGGENSTOSS
Journal:  Am J Pathol       Date:  1948-09       Impact factor: 4.307

2.  High prevalence of pancreatic disease in chronic renal failure.

Authors:  M M Avram
Journal:  Nephron       Date:  1977       Impact factor: 2.847

3.  Amylase and isoamylase activities in renal insufficiency.

Authors:  J E Berk; L Fridhandler; R L Ness
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

4.  Pancreatic-type hyperamylasemia in end-stage renal disease.

Authors:  T Araki; M Ueda; K Taketa; K Kosaka
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

5.  Pancreatic pathology in chronic dialysis patients--an autopsy study of 78 cases.

Authors:  N D Vaziri; B Dure-Smith; R Miller; M Mirahmadi
Journal:  Nephron       Date:  1987       Impact factor: 2.847

6.  Serum isoamylase measurements in pancreatitis complicating chronic renal failure.

Authors:  M D Levitt; C Ellis
Journal:  J Lab Clin Med       Date:  1979-01

7.  Serum amylase and serum lipase levels in man after administration of secretin and pancreozymin.

Authors:  P BURTON; E M HAMMOND; A A HARPER; H T HOWAT; J E SCOTT; H VARLEY
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

8.  Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis.

Authors:  N D Vaziri; D Chang; A Malekpour; S Radaht
Journal:  Am J Gastroenterol       Date:  1988-04       Impact factor: 10.864

  8 in total
  7 in total

1.  Impaired fecal elastase excretion in uremic pancreopathy.

Authors:  M Ventrucci; A Cipolla; M Middonno; C Racchini; P Simoni; K Afandi; F Grammatico; C Campieri
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Prognostic value of serum lipase levels in patients with small bowel obstruction.

Authors:  Fathima Z Kamil Faiz; Sasha Mehrabian; Mahak Saad; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-04-10

Review 3.  Acute pancreatitis in children on chronic maintenance dialysis.

Authors:  Enrico Vidal; Irene Alberici; Enrico Verrina
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

4.  Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease.

Authors:  Abdullah Ozkok; Omer Celal Elcioglu; Tahsin Cukadar; Ali Bakan; Gulsah Sasak; Kadir Gokhan Atilgan; Sabahat Alisir; Mehmet Kanbay; Adrian Covic; Ali Riza Odabas
Journal:  Int Urol Nephrol       Date:  2012-08-02       Impact factor: 2.370

5.  Safety and Efficacy of Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis in Long-Term Dialysis: A Propensity Score Analysis.

Authors:  Sung Bum Kim; Kook Hyun Kim; Tae Nyeun Kim
Journal:  Dig Dis Sci       Date:  2018-05-16       Impact factor: 3.199

6.  Alterations of exocrine pancreas in end-stage renal disease. Do they reflect a clinically relevant uremic pancreopathy?

Authors:  M Ventrucci; C Campieri; M Di Stefano; G M Ubalducci; S Li Bassi; A Di Grazia; A Giudicissi; D Festi
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

7.  Increased risk of acute pancreatitis in patients with chronic hemodialysis: a 4-year follow-up study.

Authors:  Sheng-Wen Hou; Yi-Kung Lee; Chen-Yang Hsu; Ching-Chih Lee; Yung-Cheng Su
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.